Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia

Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia

Selective cascade reporting of antibiotic susceptibilities did not have a significant impact on de-escalation from piperacillin-tazobactam (PT), duration of PT use, length of stay, or rates of acute kidney injury and Clostridioides difficile infection in patients with positive monomicrobial blood cu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infection control and hospital epidemiology 2021-10, Vol.42 (10), p.1272-1274
Hauptverfasser: Zahlanie, Yorgo, Hall, Brenton C, Wei, Wenjing, Mang, Norman S, Ortwine, Jessica K, Anderson, Shelby, Morgan, Kristi, Guzman, Tamara P, Hynan, Linda S, Prokesch, Bonnie C
Format: Artikel
Sprache:eng
Schlagworte:
Anti-Bacterial Agents - therapeutic use
Antibiotics
Antimicrobial agents
Bacteremia - drug therapy
Clinical outcomes
Concise Communication
Creatinine
E coli
Escherichia coli
Feedback
Humans
Intervention
Kidneys
Klebsiella
Patients
Piperacillin, Tazobactam Drug Combination
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Selective cascade reporting of antibiotic susceptibilities did not have a significant impact on de-escalation from piperacillin-tazobactam (PT), duration of PT use, length of stay, or rates of acute kidney injury and Clostridioides difficile infection in patients with positive monomicrobial blood cultures with either Escherichia coli or Klebsiella spp.
ISSN:0899-823X
1559-6834
DOI:10.1017/ice.2020.1385